Aion Therapeutic (XCNQ:AION) Long-Term Capital Lease Obligation : C$0.00 Mil (As of Jan. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Long-Term Capital Lease Obligation?

Aion Therapeutic's Long-Term Capital Lease Obligation for the quarter that ended in Jan. 2025 was C$0.00 Mil.

Aion Therapeutic Long-Term Capital Lease Obligation Historical Data

The historical data trend for Aion Therapeutic's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Long-Term Capital Lease Obligation Chart

Aion Therapeutic Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.30

Aion Therapeutic Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Aion Therapeutic (XCNQ:AION) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Aion Therapeutic Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Aion Therapeutic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

ANTCF:USA

Address

700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8

Website

https://www.aiontherapeutic.com

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.

Executives

Ismail Abdul Fattah	Director or Senior Officer of 10% Security Holder
Douglas Craig Wilson	Director or Senior Officer of 10% Security Holder
John Graham Simmonds	Director, Senior Officer

Aion Therapeutic Headlines

No Headlines